To make this website work, we log user data. By using Shephard's online services, you agree to our Privacy Policy, including cookie policy.

Open menu Search

RCO defends Project Mosquito cancellation, claiming investment stopped making sense

4th July 2022 - 16:00 GMT | by Tim Martin in Belfast


Concept art showing the UK's Lightweight Affordable Novel Combat Aircraft (Image: UK MoD)

Despite the UK MoD awarding Spirit Aerosystems a Project Mosquito Phase 2 design and development contract for a low-cost, uncrewed fighter aircraft valued at £30 million, the project has been cancelled without a demonstrator being built.

The Rapid Capabilities Office (RCO) in the UK RAF has told Shephard that the surprising decision to cancel Project Mosquito was based on continued investment in the effort no longer making ‘a huge amount of sense’.

Targeted at developing a low-cost, UK-made uncrewed fighter aircraft, Project Mosquito would have seen a Lightweight Affordable Novel Combat Aircraft (LANCA) demonstrator, designed by lead contractor Spirit Aerosystems Belfast and partners Northrop Grumman and Intrepid Minds, make its first flight in 2023.

However, following a detailed review, the MoD abruptly ended those plans when it announced on 24 June that the project will not move beyond a

Already have an account? Log in

Want to keep reading this article?

Read this Article

Get access to this article with a Free Basic Account

  • Original curated content, daily across air, land and naval domains
  • 2 free stories per week
  • Personalised news alerts
  • Daily and weekly newsletters
Create account

Unlimited Access

Access to all our premium news as a Premium News 365 Member. Corporate subscriptions available.

  • Original curated content, daily across air, land and naval domains
  • 14-day free trial (cancel at any time)
  • Unlimited access to all published premium news
Start your free trial
Tim Martin


Tim Martin

Tim Martin is Air Editor for Shephard Media, based in Belfast. 

Tim has experience writing …

Read full bio

Share to